Live Earnings Conference Call: Novo Nordisk A/S will host a live Q1 2026 earnings call on May 6, 2026 at 7:00AM ET. Follow this link to get details and listen to Novo Nordisk A/S's Q1 2026 earnings call when it goes live. Get details. Novo Nordisk A/S (NVO) Options Chain & Prices $44.87 +0.48 (+1.08%) Closing price 05/5/2026 03:59 PM EasternExtended Trading$45.17 +0.30 (+0.66%) As of 05/5/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVO Put and Call Options List 1/21/2028 12/17/2027 6/17/2027 3/19/2027 1/15/2027 12/18/2026 9/18/2026 8/21/2026 7/17/2026 6/18/2026 6/12/2026 6/5/2026 5/29/2026 5/22/2026 5/15/2026 5/8/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades5/8/2026$36.00$0.032Put1402883724(+158)117.13% (+11.73%)-0.018538425/8/2026$36.00$8.866Call16 - - 118(+0)118.32% (+12.92%)0.981427135/8/2026$36.50$0.040Put102 - 68108(+7)115.91% (+13.06%)-0.022538315/8/2026$36.50$8.413Call51 - 53(+0)115.91% (+13.06%)0.97742755/8/2026$37.00$0.050Put3210111078(+0)113.48% (+13.02%)-0.027882145/8/2026$37.00$7.923Call6 - 1238(+0)113.48% (+13.02%)0.97208565/8/2026$37.50$0.063Put701834260(+2)110.77% (+12.47%)-0.034613225/8/2026$37.50$7.397Call2 - - 96(+48)111.10% (+12.81%)0.96484525/8/2026$38.00$0.079Put10025131155(+344)109.21% (+12.95%)-0.043092405/8/2026$38.00$6.915Call5 - - 447(+45)109.08% (+12.79%)0.9562325 Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 5/8/2026$38.50$0.102Put24713277296(-4)107.26% (+12.74%)-0.0545291475/8/2026$38.50$6.475Call2 - - 65(-4)107.38% (+12.86%)0.94627115/8/2026$39.00$0.129Put1936557697(+81)105.76% (+12.79%)-0.06689645/8/2026$39.00$5.966Call16121934(-15)105.66% (+12.66%)0.93206965/8/2026$39.50$0.165Put1142918804(+119)104.35% (+12.64%)-0.083082385/8/2026$39.50$5.503Call20312126(-1)104.25% (+12.53%)0.91564775/8/2026$40.00$0.214Put1,3295055889534(+1201)101.39% (+10.53%)-0.1042292195/8/2026$40.00$5.050Call11658251999(-88)112.87% (+22.18%)0.895748395/8/2026$40.50$0.272Put43724776414(+104)101.69% (+11.83%)-0.127818845/8/2026$40.50$4.608Call15 - 121480(-100)101.96% (+12.10%)0.87222275/8/2026$41.00$0.346Put8,952324716790(+154)101.66% (+12.43%)-0.1556574225/8/2026$41.00$4.182Call53832191446(+64)101.14% (+11.91%)0.844418605/8/2026$41.50$0.429Put5203794297(+121)100.48% (+11.71%)-0.185029845/8/2026$41.50$3.805Call945010790(+4)100.48% (+11.70%)0.815076195/8/2026$42.00$0.545Put1,4772287141075(+773)100.96% (+12.50%)-0.2235312195/8/2026$42.00$3.381Call12528481818(-50)99.86% (+11.40%)0.77664445/8/2026$42.50$0.675Put54944429161(+56)99.86% (+11.57%)-0.263359885/8/2026$42.50$3.011Call144396345(-28)99.44% (+11.14%)0.736887325/8/2026$43.00$0.816Put1,411201297425(+135)99.16% (+10.92%)-0.3031134055/8/2026$43.00$2.693Call388324332608(-78)99.16% (+10.92%)0.697201455/8/2026$43.50$1.007Put33331176401(+145)99.91% (+11.62%)-0.352454725/8/2026$43.50$2.343Call13235588297(+20)98.96% (+10.67%)0.647963485/8/2026$44.00$1.211Put4741841201576(+1388)99.25% (+10.66%)-0.400341355/8/2026$44.00$2.047Call535971232201(+318)96.38% (+7.94%)0.6002041015/8/2026$44.50$1.442Put800403283442(+285)100.18% (+11.50%)-0.4492821805/8/2026$44.50$1.778Call41694164996(+573)98.94% (+9.90%)0.5513891085/8/2026$45.00$1.679Put1822419194(+70)99.47% (+10.48%)-0.494438815/8/2026$45.00$1.555Call2,5447757004824(+570)99.07% (+10.08%)0.5063387335/8/2026$45.50$1.960Put76 - 10(+0)99.29% (+9.90%)-0.54290745/8/2026$45.50$1.318Call41522869747(+17)98.10% (+8.71%)0.4541551015/8/2026$46.00$2.290Put7575 - 44(+0)99.63% (+9.78%)-0.593694115/8/2026$46.00$1.142Call10,1692,2477734068(+1782)99.60% (+9.74%)0.4111679335/8/2026$46.50$2.595Put85 - 6(+0)99.99% (+9.58%)-0.63478935/8/2026$46.50$0.971Call370132452702(+2491)99.99% (+9.58%)0.366415995/8/2026$47.00$2.947Put1515 - 201(+0)100.44% (+9.42%)-0.67704815/8/2026$47.00$0.810Call3,5852291611193(+270)100.32% (+9.31%)0.3209114695/8/2026$47.50$0.683Call2,097993479571(+204)101.00% (+9.31%)0.2820832155/8/2026$48.00$0.584Call1,6431704041327(+652)101.53% (+9.07%)0.2494462675/8/2026$48.50$4.116Put32 - 0(+0)102.17% (+8.89%)-0.78467235/8/2026$48.50$0.489Call596126321141(+79)102.17% (+8.87%)0.217029875/8/2026$49.00$4.570Put4 - 21(+0)102.92% (+8.74%)-0.81619245/8/2026$49.00$0.409Call2163718481(+29)103.83% (+9.65%)0.187977835/8/2026$49.50$4.970Put1 - - 0(+0)103.60% (+8.44%)-0.83965615/8/2026$49.50$0.342Call3482014782(+31)103.60% (+8.44%)0.162197945/8/2026$50.00$5.414Put5535 - 18(+1)104.40% (+8.19%)-0.86237985/8/2026$50.00$0.286Call6,7792,3571,6114365(+616)104.77% (+8.43%)0.1395265955/8/2026$51.00$6.328Put9090 - 45(+45)106.18% (+7.62%)-0.89936345/8/2026$51.00$0.196Call9,1835737858420(+250)104.49% (+5.96%)0.101167426End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Novartis Options Sanofi Options GSK Options Takeda Pharmaceutical Options argenex Options Teva Pharmaceutical Industries Options Insmed Options Revolution Medicines Options BioNTech Options Roivant Sciences Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:NVO) was last updated on 5/6/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredHow to collect $1,170/month from silverThere is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...Investors Alley | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredDid you miss The Dark AI Summit?Over 55,000 people attended Jeff Brown's Dark AI Summit, where he revealed a private AI company he believes ho...Brownstone Research | SponsoredIran War Update: Trump’s Hand-Written Letter Reveals What Comes NextJim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...Paradigm Press | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
